IDSA: No Recommendations for COVID-19 Treatment for Now

Interim guidance from the IDSA recommends hydroxychloroquine/chloroquine in the context of a clinical trial and hydroxychloroquine/chloroquine plus azithromycin only' in context of a clinical trial.
Source: WebMD Health - Category: Consumer Health News Source Type: news